KSIP platform is an AI-driven data analysis platform that analyzes data from millions of scientific and clinical trial documents to identify synergistic drug combinations or new uses for existing or failed drugs (drug repositioning). We perform detailed literature analysis from millions of scientific documents to identify new uses for assets to aid in decision-making and are also able to develop formulations of these products at our CDMO facility to supply finished products to our customers. We help companies with identifying ‘second medical use’ claim IP. Our approach empowers drug developers to harness the untapped potential within their assets and explore fresh avenues for innovation and impact.